Timetable 2024

09:00 – 09:15 Offi­cial opening
09:15 – 09:40 Tobias Bald
Uni­ver­si­ty of Bonn, Germany
NK cell plas­tic­i­ty in cancer
09:40 – 10:05 Kazuyo Moro
RIKEN/​Osaka Uni­ver­si­ty, Japan
The Impact of Appen­dec­to­my on Ulcer­a­tive Colitis
10:05 – 10:30 Jakub Gołąb
Med­ical Uni­ver­si­ty of War­saw, Poland
The roles of arginas­es in mit­i­ga­tion of anti­tu­mor immunity
10:30 – 10:55 Aurélie Poli
Lux­em­bourg Insti­tute of Health, Luxembourg
Aller­goOn­col­o­gy: Lessons Learned from the Aller­gy-Glioblas­toma Connection
10:55 – 11:20 Alexan­dros Drainas
Bio­Med X, Germany
The quest to elim­i­nate ecD­NA in can­cer cells 
11:20 – 11:40 Break
11:40 – 12:05 Andrew Shep­herd
Uni­ver­si­ty of Texas MD Ander­son Can­cer Cen­ter, USA
Pain neu­rons con­trol can­cer immunosurveillance
12:05 – 12:30 Hrvo­je Milet­ic
Uni­ver­si­ty of Bergen, Norway 
Cell com­mu­ni­ca­tion and mito­chon­dria trans­fer in brain tumors
12:30 – 12:55 Anne-Marie Hee­gaard
Uni­ver­si­ty of Copen­hagen, Denmark
Pain in Mul­ti­ple Myelo­ma – inter­ac­tion of the can­cer microen­vi­ron­ment with the sen­so­ry ner­vous system
12:55 – 13:20 Sébastien Tal­bot (online)
Queen’s Uni­ver­si­ty, ON, Canada
Periph­er­al Nerve Injury Induced by Col­orec­tal Can­cer: Mech­a­nisms and Impli­ca­tions for Chemother­a­py-Induced Periph­er­al Neuropathy
13:20 – 13:30 Spon­sor pre­sen­ta­tion: Altium
13:30 – 14:30 Lunch
14:30 – 14:55 Clau­dio Ballabio
The Fran­cis Crick Insti­tute, Unit­ed Kingdom
Tumour intrin­sic elec­tri­cal activ­i­ty dri­ves small-cell lung can­cer progression 
14:55 – 15:20 Yuan Pan (online)
Uni­ver­si­ty of Texas MD Ander­son Can­cer Cen­ter, USA
The Can­cer Neu­ro­science of Neu­rofi­bro­mato­sis type 1 (NF1)
15:20 – 15:45 Domini­ka Nowis
Med­ical Uni­ver­si­ty of War­saw, Poland
The use of mRNA-based immunother­a­pies in exper­i­men­tal oncology
15:45 – 16:10 Hele­na Florindo
Uni­ver­si­ty of Lis­bon, Portugal
Unveil­ing Sol­id Tumor Microen­vi­ron­ment for rev­o­lu­tion­ary nano-immunotherapies
16:10 – 17:00 Break (Indus­try Con­tact Point intro­duc­tion to Match­mak­ing + Match­mak­ing Session)
17:00 – 18:00 Open­ing Keynote Melody Swartz
Uni­ver­si­ty of Chica­go, USA
The yin and yang of tumor-asso­ci­at­ed lym­phat­ics in metas­ta­sis and anti-tumor immunity

09:00 – 10:30 EIT Health — Morn­ing Health Talks
EIT Morning Talks Moni­ka Ślęzak (pan­el mod­er­a­tor)
Indus­try Con­tact Point Med­ical Tech­nolo­gies and Health, Łukasiewicz – PORT 

Marek Kozłows­ki
Ven­ture Cap­i­tal – Life Sci­ence & Health­care NRW.Venture

Michał Malewicz
Life Sci­ence & Biotech­nol­o­gy Cen­ter, Łukasiewicz – PORT 

Michał Zaw­isza Woy­czyńs­ki
Sav­ing Kids with Can­cer Foundation 

Marek Sipow­icz
WPD Phar­ma­ceu­ti­cals Inc. 

Moni­ka Litwin
Low­er Sile­sian Cen­ter of Oncol­o­gy, Pul­monolo­gy and Hematology 

Mag­dale­na Sobo­cińs­ka
NU-MED Spe­cial­ist Oncol­o­gy Hos­pi­tal in Tomaszów Mazowiecki 

Mag­dale­na Ciążyńs­ka
NU-MED Spe­cial­ist Oncol­o­gy Hos­pi­tal in Tomaszów Mazowiecki 
10:30 – 10:40 Break
10:40 – 11:05 Car­los-Fil­ipe Pereira
Lund Uni­ver­si­ty, Sweden 
Empow­er­ing Can­cer Immunother­a­py with Cel­lu­lar Reprogramming
11:05 – 11:30 Rafael Blan­co Domínguez
Uni­ver­si­ty of Lis­bon, Portugal
Delta One T cells in Can­cer Immunotherapy
11:30 – 11:55 Helen Kakkassery
King’s Col­lege Lon­don, Unit­ed Kingdom 
Inves­ti­gat­ing the immune sur­veil­lance mech­a­nisms in atyp­i­cal respon­ders of stage IV breast can­cers fol­low­ing stan­dard of care chemo — and tar­get­ed therapies
11:55 – 12:55 Con­fer­ence brunch
12:55 – 13:20 Thanus­suyah Alaguthu­rai
King’s Col­lege Lon­don, Unit­ed Kingdom 
Trans­la­tion­al Research Pro­gramme- Facil­i­tat­ing oncol­o­gy research at Guy’s
13:20 – 13:45 Mar­co Gus­tav
Dres­den Uni­ver­si­ty of Tech­nol­o­gy, Germany 
Deep Learn­ing-based Bio­mark­ers for Pre­ci­sion Oncology
13:45 – 13:55 Break
13:55 – 14:20 Christoph Klose
Char­ité – Berlin Uni­ver­si­ty Med­i­cine, Germany 
Neu­ro-immune inter­ac­tions at bar­ri­er surfaces
14:20 – 14:45 Boże­na Kamińs­ka
Nenc­ki Insti­tute of Exper­i­men­tal Biol­o­gy of the Pol­ish Acad­e­my of Sci­ences, Poland 
Tam­ing tumor microen­vi­ron­ment with siR­NAs and inno­v­a­tive nanocar­ri­ers in malig­nant gliomas
14:45 – 15:55 Com­pa­ny session
Mol­e­cure, Celon Phar­ma, Ryvu Ther­a­peu­tics, Inter­na­tion­al Cen­tre for Can­cer Vac­cine Sci­ence (Uni­ver­si­ty of Gdańsk), Ardi­gen, Cel­lis, Can­cer Center
15:55 – 16:00 Offi­cial closure

09:00 – 09:15 Offi­cial opening
09:15 – 09:40 Tobias Bald
Uni­ver­si­ty of Bonn, Germany
NK cell plas­tic­i­ty in cancer
09:40 – 10:05 Kazuyo Moro
RIKEN/​Osaka Uni­ver­si­ty, Japan
The Impact of Appen­dec­to­my on Ulcer­a­tive Colitis
10:05 – 10:30 Jakub Gołąb
Med­ical Uni­ver­si­ty of War­saw, Poland
The roles of arginas­es in mit­i­ga­tion of anti­tu­mor immunity
10:30 – 10:55 Aurélie Poli
Lux­em­bourg Insti­tute of Health, Luxembourg
Aller­goOn­col­o­gy: Lessons Learned from the Aller­gy-Glioblas­toma Connection
10:55 – 11:20 Alexan­dros Drainas
Bio­Med X, Germany
The quest to elim­i­nate ecD­NA in can­cer cells 
11:20 – 11:40 Break
11:40 – 12:05 Andrew Shep­herd
Uni­ver­si­ty of Texas MD Ander­son Can­cer Cen­ter, USA
Pain neu­rons con­trol can­cer immunosurveillance
12:05 – 12:30 Hrvo­je Milet­ic
Uni­ver­si­ty of Bergen, Norway 
Cell com­mu­ni­ca­tion and mito­chon­dria trans­fer in brain tumors
12:30 – 12:55 Anne-Marie Hee­gaard
Uni­ver­si­ty of Copen­hagen, Denmark
Pain in Mul­ti­ple Myelo­ma – inter­ac­tion of the can­cer microen­vi­ron­ment with the sen­so­ry ner­vous system
12:55 – 13:20 Sébastien Tal­bot (online)
Queen’s Uni­ver­si­ty, ON, Canada
Periph­er­al Nerve Injury Induced by Col­orec­tal Can­cer: Mech­a­nisms and Impli­ca­tions for Chemother­a­py-Induced Periph­er­al Neuropathy
13:20 – 13:30 Spon­sor pre­sen­ta­tion: Altium
13:30 – 14:30 Lunch
14:30 – 14:55 Clau­dio Ballabio
The Fran­cis Crick Insti­tute, Unit­ed Kingdom
Tumour intrin­sic elec­tri­cal activ­i­ty dri­ves small-cell lung can­cer progression 
14:55 – 15:20 Yuan Pan (online)
Uni­ver­si­ty of Texas MD Ander­son Can­cer Cen­ter, USA
The Can­cer Neu­ro­science of Neu­rofi­bro­mato­sis type 1 (NF1)
15:20 – 15:45 Domini­ka Nowis
Med­ical Uni­ver­si­ty of War­saw, Poland
The use of mRNA-based immunother­a­pies in exper­i­men­tal oncology
15:45 – 16:10 Hele­na Florindo
Uni­ver­si­ty of Lis­bon, Portugal
Unveil­ing Sol­id Tumor Microen­vi­ron­ment for rev­o­lu­tion­ary nano-immunotherapies
16:10 – 17:00 Break (Indus­try Con­tact Point intro­duc­tion to Match­mak­ing + Match­mak­ing Session)
17:00 – 18:00 Open­ing Keynote Melody Swartz
Uni­ver­si­ty of Chica­go, USA
The yin and yang of tumor-asso­ci­at­ed lym­phat­ics in metas­ta­sis and anti-tumor immunity

09:00 – 10:30 EIT Health — Morn­ing Health Talks
EIT Morning Talks Moni­ka Ślęzak (pan­el mod­er­a­tor)
Indus­try Con­tact Point Med­ical Tech­nolo­gies and Health, Łukasiewicz – PORT 

Marek Kozłows­ki
Ven­ture Cap­i­tal – Life Sci­ence & Health­care NRW.Venture

Michał Malewicz
Life Sci­ence & Biotech­nol­o­gy Cen­ter, Łukasiewicz – PORT 

Michał Zaw­isza Woy­czyńs­ki
Sav­ing Kids with Can­cer Foundation 

Marek Sipow­icz
WPD Phar­ma­ceu­ti­cals Inc. 

Moni­ka Litwin
Low­er Sile­sian Cen­ter of Oncol­o­gy, Pul­monolo­gy and Hematology 

Mag­dale­na Sobo­cińs­ka
NU-MED Spe­cial­ist Oncol­o­gy Hos­pi­tal in Tomaszów Mazowiecki 

Mag­dale­na Ciążyńs­ka
NU-MED Spe­cial­ist Oncol­o­gy Hos­pi­tal in Tomaszów Mazowiecki 
10:30 – 10:40 Break
10:40 – 11:05 Car­los-Fil­ipe Pereira
Lund Uni­ver­si­ty, Sweden 
Empow­er­ing Can­cer Immunother­a­py with Cel­lu­lar Reprogramming
11:05 – 11:30 Rafael Blan­co Domínguez
Uni­ver­si­ty of Lis­bon, Portugal
Delta One T cells in Can­cer Immunotherapy
11:30 – 11:55 Helen Kakkassery
King’s Col­lege Lon­don, Unit­ed Kingdom 
Inves­ti­gat­ing the immune sur­veil­lance mech­a­nisms in atyp­i­cal respon­ders of stage IV breast can­cers fol­low­ing stan­dard of care chemo — and tar­get­ed therapies
11:55 – 12:55 Con­fer­ence brunch
12:55 – 13:20 Thanus­suyah Alaguthu­rai
King’s Col­lege Lon­don, Unit­ed Kingdom 
Trans­la­tion­al Research Pro­gramme- Facil­i­tat­ing oncol­o­gy research at Guy’s
13:20 – 13:45 Mar­co Gus­tav
Dres­den Uni­ver­si­ty of Tech­nol­o­gy, Germany 
Deep Learn­ing-based Bio­mark­ers for Pre­ci­sion Oncology
13:45 – 13:55 Break
13:55 – 14:20 Christoph Klose
Char­ité – Berlin Uni­ver­si­ty Med­i­cine, Germany 
Neu­ro-immune inter­ac­tions at bar­ri­er surfaces
14:20 – 14:45 Boże­na Kamińs­ka
Nenc­ki Insti­tute of Exper­i­men­tal Biol­o­gy of the Pol­ish Acad­e­my of Sci­ences, Poland 
Tam­ing tumor microen­vi­ron­ment with siR­NAs and inno­v­a­tive nanocar­ri­ers in malig­nant gliomas
14:45 – 15:55 Com­pa­ny session
Mol­e­cure, Celon Phar­ma, Ryvu Ther­a­peu­tics, Inter­na­tion­al Cen­tre for Can­cer Vac­cine Sci­ence (Uni­ver­si­ty of Gdańsk), Ardi­gen, Cel­lis, Can­cer Center
15:55 – 16:00 Offi­cial closure